Controladora Vuela Compania de Aviacion S.A.B. de C.V. ADS
Controladora Vuela Compania de Aviacion S.A.B. de C.V. ADS (VLRS) Financials Oct 16, 2014, 3:02 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Controladora Vuela Compania de Aviacion S.A.B. de C.V. ADS
Fiscal year is January-December. All values MXN millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 5.05B 6.78B 8.88B 11.69B 13B
Cost of Goods Sold (COGS) incl. D&A 4.17B 5.44B 8.26B 10.32B 11.85B
COGS excluding D&A 4.13B 5.37B 8.16B 10.11B 11.55B
Depreciation & Amortization Expense 45.93M 61.69M 102.98M 211M 301.53M
Depreciation - 44.9M 82.92M 187.13M 269.35M
Amortization of Intangibles - 16.8M 20.06M 23.87M 32.18M
Gross Income 873.95M 1.34B 616.31M 1.36B 1.15B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 643.85M 712.36M 908.86M 888.4M 907.23M
Research & Development - - - - -
Other SG&A 643.85M 712.36M 908.86M 888.4M 907.23M
Other Operating Expense 0 118.87M 153.21M 152.05M 0
Unusual Expense 0 - - - 29.42M
EBIT after Unusual Expense 0 - - - (29.42M)
Non Operating Income/Expense 75.43M (59.44M) 182.92M (41.11M) 165.9M
Non-Operating Interest Income 4.82M 5.09M 5.54M 13.61M 24.77M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 86.86M 52.22M 57.72M 89.73M 125.74M
Gross Interest Expense 86.86M 62.25M 85.82M 154.18M 150.93M
Interest Capitalized - 10.03M 28.1M 64.45M 25.2M
Pretax Income 223.49M 404.43M (315.01M) 206.8M 282.84M
Income Tax 2.22M (238.68M) 476,000 3.48M 17.55M
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - 0
Equity in Affiliates - - - - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 221.27M 643.11M (315.49M) 203.32M 265.29M
Minority Interest Expense 24.62M 70.88M (21.95M) (11.92M) (3.39M)
Net Income 196.66M 572.23M (293.54M) 215.24M 268.68M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 196.66M 572.23M (293.54M) 215.24M 268.68M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 196.66M 572.23M (293.54M) 215.24M 268.68M
EPS (Basic) - 2.64 (1.36) 1.30 0.31
Basic Shares Outstanding - 216.47M 216.47M 165.26M 865.58M
EPS (Diluted) - 2.64 (1.36) 1.30 0.31
Diluted Shares Outstanding - 216.47M 216.47M - 865.58M
EBITDA 276.03M 572.69M (342.77M) 535.03M 548.86M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Top 5 Most Recently Viewed Articles
BioVaxys Technology Corp. Announces Private Placement Offering BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) is thrilled to share its plans for a strategic move that aims to elevate its operational capabilities. The company intends to initiate a non-brokered private placement offering, introducing up to 14,285,715 units at a price of CAD$0.07 each. This initiative is...
Continue Reading
Cardiff Oncology Completes Significant Stock Offering Cardiff Oncology, Inc. (Nasdaq: CRDF) has recently made headlines with its successful pricing of an underwritten offering, targeting a remarkable $40 million. This offering consists of 15,384,619 shares of its common stock, priced at $2.60 per share, with all shares being offered by the Company itself. The...
Continue Reading
Sungrow and Globeleq Join Forces on Groundbreaking Energy Project Sungrow, a prominent name in the renewable energy sector, and Globeleq, a trusted independent power producer, have made a significant commitment by signing a term sheet. This partnership focuses on the supply and long-term service for the ambitious 153MW / 612MWh Red Sands Battery Energy Storage System...
Continue Reading
Helios Technologies Launches the Versatile S35 Display Helios Technologies, Inc. (NYSE: HLIO), known for its expertise in highly engineered motion control and electronic controls technology, has recently introduced the S35 display. This new addition showcases a unique blend of advanced technology, rugged durability, and user-friendliness, making it an exceptional...
Continue Reading
Ameriprise Financial Achieves All-Time High Ameriprise Financial Inc (NYSE: AMP) has recently marked an extraordinary achievement with its stock price reaching an all-time high of $524.01. This significant increase not only highlights the company’s performance but also reflects a robust surge in investor confidence, demonstrated by a remarkable 65.08% increase over the...
Continue Reading